UBS Oncology Impact Fund L.P., 10% Owner at Harpoon Therapeutics, Inc. (HARP), sold 447 shares at $14.00 ($6K) on 2019-02-12, disclosed to the SEC on 2019-02-14.
Open-market sale of $6k HARP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HOWL | SELL | 2025-10-29 | $685K | — | Filing → |
| ITOS | SELL | 2021-09-27 | $3.2M | — | Filing → |
| CGEM | SELL | 2021-09-02 | $1.3M | — | Filing → |